120 related articles for article (PubMed ID: 10397247)
21. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
22. Lymphoblastoid cell lines differing in p53 status show clear differences in basal gene expression with minor changes after irradiation.
Zschenker O; Borgmann K; Streichert T; Meier I; Wrona A; Dikomey E
Radiother Oncol; 2006 Aug; 80(2):236-49. PubMed ID: 16905214
[TBL] [Abstract][Full Text] [Related]
23. Hypermutable change of human UV(r)-1 cells by p53 overexpression.
Sugita T; Hiwasa T; Nomura J; Kita K; Hiroshima K; Suzuki H; Sekiya S; Suzuki N
Biochem Biophys Res Commun; 2001 Dec; 289(3):756-62. PubMed ID: 11726213
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis induced by high-LET radiations is not affected by cellular p53 gene status.
Takahashi A; Matsumoto H; Furusawa Y; Ohnishi K; Ishioka N; Ohnishi T
Int J Radiat Biol; 2005 Aug; 81(8):581-6. PubMed ID: 16298939
[TBL] [Abstract][Full Text] [Related]
25. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells.
Honma M; Hayashi M
Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812
[TBL] [Abstract][Full Text] [Related]
26. Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways.
Zeng M; Narayanan L; Xu XS; Prolla TA; Liskay RM; Glazer PM
Cancer Res; 2000 Sep; 60(17):4889-93. PubMed ID: 10987303
[TBL] [Abstract][Full Text] [Related]
27. C-terminal peptides of p53 molecules enhance radiation-induced apoptosis in human mutant p53 cancer cells.
Ohnishi K; Inaba H; Yasumoto J; Yuki K; Takahashi A; Ohnishi T
Apoptosis; 2004 Sep; 9(5):591-7. PubMed ID: 15314287
[TBL] [Abstract][Full Text] [Related]
28. Abrogation of radiation-inducible telomerase upregulation in HPV16 E6 transfectants of human lymphoblasts.
Neuhof D; Auberger F; Ruess A; Wenz F; Weber KJ
Strahlenther Onkol; 2004 Jan; 180(1):52-6. PubMed ID: 14704845
[TBL] [Abstract][Full Text] [Related]
29. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53.
Turenne GA; Paul P; Laflair L; Price BD
Oncogene; 2001 Aug; 20(37):5100-10. PubMed ID: 11526498
[TBL] [Abstract][Full Text] [Related]
30. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
31. p53 protects against skin cancer induction by UV-B radiation.
Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
[TBL] [Abstract][Full Text] [Related]
32. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
Smardová J; Pavlová S; Svitáková M; Grochová D; Ravcuková B
Oncol Rep; 2005 Oct; 14(4):901-7. PubMed ID: 16142349
[TBL] [Abstract][Full Text] [Related]
33. Threshold effects of nitric oxide-induced toxicity and cellular responses in wild-type and p53-null human lymphoblastoid cells.
Li CQ; Pang B; Kiziltepe T; Trudel LJ; Engelward BP; Dedon PC; Wogan GN
Chem Res Toxicol; 2006 Mar; 19(3):399-406. PubMed ID: 16544944
[TBL] [Abstract][Full Text] [Related]
34. Adenomatous polyposis coli gene mutation and decreased wild-type p53 protein expression in oral submucous fibrosis: a preliminary investigation.
Liao PH; Lee TL; Yang LC; Yang SH; Chen SL; Chou MY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):202-7. PubMed ID: 11505268
[TBL] [Abstract][Full Text] [Related]
35. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
36. Role of p53 mutations, protein function and DNA damage for the radiosensitivity of human tumour cells.
Böhnke A; Westphal F; Schmidt A; El-Awady RA; Dahm-Daphi J
Int J Radiat Biol; 2004 Jan; 80(1):53-63. PubMed ID: 14761850
[TBL] [Abstract][Full Text] [Related]
37. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM
Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
[TBL] [Abstract][Full Text] [Related]
38. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines.
Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M
Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912
[TBL] [Abstract][Full Text] [Related]
39. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
[TBL] [Abstract][Full Text] [Related]
40. The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.
Longley DB; Boyer J; Allen WL; Latif T; Ferguson PR; Maxwell PJ; McDermott U; Lynch M; Harkin DP; Johnston PG
Cancer Res; 2002 May; 62(9):2644-9. PubMed ID: 11980662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
